This is a discussion on Finding no magic for 'Merlin,' Sir Evans shifts focus within the Biotechnology News forum, part of the Industry News and Updates category; Sir Christopher Evans' is scrapping Merlin Biosciences and transferring the early-stage venture funds to the newly-formed Excalibur, which ...
|
|||||||
| Register | Help | Members List | Mark Forums Read |
|
|||
|
Sir Christopher Evans' is scrapping Merlin Biosciences and transferring the early-stage venture funds to the newly-formed Excalibur, which will shift focus to late-stage therapies. That's bitter news Read more...
More... |